{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-19T04:31:47.156713+00:00","published_at":"2026-10-18T07:11:51.27144+00:00","section":"relationships","data":{"state":"PUBLISHED","relationships":[{"relationship_id":"alpha:relationship:seat_on:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:6:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"seat_on","from_id":"alpha:person:alderya-therapeutics-nvax","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"Alderya Therapeutics","to_label":"NOVAVAX INC","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:175d30715a6589cc3390c7c5ef5468d1daa3d6d31474b1cf67fdbf78252d35bf"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:7:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"seat_on","from_id":"alpha:person:amicus-therapeutics-nvax","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"Amicus Therapeutics","to_label":"NOVAVAX INC","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:175d30715a6589cc3390c7c5ef5468d1daa3d6d31474b1cf67fdbf78252d35bf"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:8:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"seat_on","from_id":"alpha:person:auravax-therapeutics-nvax","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"AuraVax Therapeutics","to_label":"NOVAVAX INC","valid_from":"2025-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:175d30715a6589cc3390c7c5ef5468d1daa3d6d31474b1cf67fdbf78252d35bf"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:9:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"seat_on","from_id":"alpha:person:brii-biosciences-nvax","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"Brii Biosciences","to_label":"NOVAVAX INC","valid_from":"2022-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:175d30715a6589cc3390c7c5ef5468d1daa3d6d31474b1cf67fdbf78252d35bf"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:10:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"seat_on","from_id":"alpha:person:charles-w-newton-nvax","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"Charles W. Newton","to_label":"NOVAVAX INC","valid_from":"2023-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:175d30715a6589cc3390c7c5ef5468d1daa3d6d31474b1cf67fdbf78252d35bf"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:15:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"seat_on","from_id":"alpha:person:maryland-life-sciences-advisory-nvax","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"Maryland Life Sciences Advisory","to_label":"NOVAVAX INC","valid_from":"2025-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:15","evidence_ids":["alpha:projection-evidence:document:175d30715a6589cc3390c7c5ef5468d1daa3d6d31474b1cf67fdbf78252d35bf"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:16:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"seat_on","from_id":"alpha:person:opus-genetics-nvax","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"Opus Genetics","to_label":"NOVAVAX INC","valid_from":"2010-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:16","evidence_ids":["alpha:projection-evidence:document:175d30715a6589cc3390c7c5ef5468d1daa3d6d31474b1cf67fdbf78252d35bf"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:5:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"seat_on","from_id":"alpha:person:david-mott-nvax","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"David Mott","to_label":"NOVAVAX INC","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e"]},{"relationship_id":"alpha:relationship:chairs_board:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:5:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"chairs_board","from_id":"alpha:person:david-mott-nvax","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"David Mott","to_label":"NOVAVAX INC","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:11:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"seat_on","from_id":"alpha:person:gregg-h-alton","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"Gregg H. Alton","to_label":"NOVAVAX INC","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:12:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"seat_on","from_id":"alpha:person:john-c-jacobs","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"John C. Jacobs","to_label":"NOVAVAX INC","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:13:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"seat_on","from_id":"alpha:person:john-w-shiver","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"John W. Shiver","to_label":"NOVAVAX INC","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:14:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"seat_on","from_id":"alpha:person:margaret-g-mcglynn-novavax-inc","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"Margaret G. McGlynn","to_label":"NOVAVAX INC","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:14","evidence_ids":["alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:17:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"seat_on","from_id":"alpha:person:rachel-k-king","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"Rachel K. King","to_label":"NOVAVAX INC","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:17","evidence_ids":["alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:18:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"seat_on","from_id":"alpha:person:richard-h-douglas","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"Richard H. Douglas","to_label":"NOVAVAX INC","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:18","evidence_ids":["alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:19:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"seat_on","from_id":"alpha:person:richard-j-rodgers","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"Richard J. Rodgers","to_label":"NOVAVAX INC","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:19","evidence_ids":["alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:22:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"executive_of","from_id":"alpha:person:jeffrey-d-kelly","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"Jeffrey D. Kelly","to_label":"NOVAVAX INC","valid_from":"2026-04-27","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:22","evidence_ids":["alpha:projection-evidence:document:f037cb8859aa9e25095f29e05764b56b10350ab06f66b8c57eadc9c4f7908255"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:24:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"executive_of","from_id":"alpha:person:john-trizzino","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"John Trizzino","to_label":"NOVAVAX INC","valid_from":"2026-04-27","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:24","evidence_ids":["alpha:projection-evidence:document:a36ac2691aed7a3541ac0f69a3e80a59a885ba87b4e8c70f9ebaf3fae39fdcff"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:26:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"executive_of","from_id":"alpha:person:michael-casey","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"Michael Casey","to_label":"NOVAVAX INC","valid_from":"2026-04-27","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:26","evidence_ids":["alpha:projection-evidence:document:61de0a12d94edbeccc0e88cc44025f89f3babb4f66743bdee16ded6b590ccf32"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:27:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"executive_of","from_id":"alpha:person:ruxandra-draghia-akli","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"Ruxandra Draghia-Akli","to_label":"NOVAVAX INC","valid_from":"2026-04-27","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:27","evidence_ids":["alpha:projection-evidence:document:c77f87bd20375542c8cddf23567e8e094e3888e4abe3c6f916a0fe7a84b07fb6"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:20:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"executive_of","from_id":"alpha:person:elaine-o-hara","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"Elaine O'Hara","to_label":"NOVAVAX INC","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:20","evidence_ids":["alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:21:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"executive_of","from_id":"alpha:person:james-p-kelly","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"James P. Kelly","to_label":"NOVAVAX INC","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:21","evidence_ids":["alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:23:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"executive_of","from_id":"alpha:person:john-c-jacobs","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"John C. Jacobs","to_label":"NOVAVAX INC","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:23","evidence_ids":["alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:25:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","relationship_type":"executive_of","from_id":"alpha:person:mark-j-casey","to_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","from_label":"Mark J. Casey","to_label":"NOVAVAX INC","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:25","evidence_ids":["alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e"]}]},"claims":[{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:5","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-mott-nvax","object_label":"David Mott","object_source_name_forms":[],"value":"David Mott: Chairman of the Board","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-mott-nvax","name":"David Mott"},"title":"Chairman of the Board","role_category":"director","committee":null,"is_board_chair":true,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001628280-26-027328","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-12T16:15:04.417067+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:6","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:alderya-therapeutics-nvax","object_label":"Alderya Therapeutics","object_source_name_forms":[],"value":"Alderya Therapeutics: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:alderya-therapeutics-nvax","name":"Alderya Therapeutics"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:175d30715a6589cc3390c7c5ef5468d1daa3d6d31474b1cf67fdbf78252d35bf","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A nvax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T01:29:30.958071+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:7","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:amicus-therapeutics-nvax","object_label":"Amicus Therapeutics","object_source_name_forms":[],"value":"Amicus Therapeutics: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:amicus-therapeutics-nvax","name":"Amicus Therapeutics"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:175d30715a6589cc3390c7c5ef5468d1daa3d6d31474b1cf67fdbf78252d35bf","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A nvax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T01:29:30.958071+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:8","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:auravax-therapeutics-nvax","object_label":"AuraVax Therapeutics","object_source_name_forms":[],"value":"AuraVax Therapeutics: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:auravax-therapeutics-nvax","name":"AuraVax Therapeutics"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:175d30715a6589cc3390c7c5ef5468d1daa3d6d31474b1cf67fdbf78252d35bf","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A nvax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T01:29:30.958071+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:9","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:brii-biosciences-nvax","object_label":"Brii Biosciences","object_source_name_forms":[],"value":"Brii Biosciences: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:brii-biosciences-nvax","name":"Brii Biosciences"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:175d30715a6589cc3390c7c5ef5468d1daa3d6d31474b1cf67fdbf78252d35bf","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A nvax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T01:29:30.958071+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:10","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:charles-w-newton-nvax","object_label":"Charles W. Newton","object_source_name_forms":[],"value":"Charles W. Newton: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:charles-w-newton-nvax","name":"Charles W. Newton"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:175d30715a6589cc3390c7c5ef5468d1daa3d6d31474b1cf67fdbf78252d35bf","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A nvax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T01:29:30.958071+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:11","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gregg-h-alton","object_label":"Gregg H. Alton","object_source_name_forms":[],"value":"Gregg H. Alton: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gregg-h-alton","name":"Gregg H. Alton"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001628280-26-027328","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-12T16:15:04.417067+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:12","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:john-c-jacobs","object_label":"John C. Jacobs","object_source_name_forms":[],"value":"John C. Jacobs: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:john-c-jacobs","name":"John C. Jacobs"},"title":"President and Chief Executive Officer","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001628280-26-027328","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-12T16:15:04.417067+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:13","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:john-w-shiver","object_label":"John W. Shiver","object_source_name_forms":[],"value":"John W. Shiver: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:john-w-shiver","name":"John W. Shiver"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001628280-26-027328","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-12T16:15:04.417067+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:14","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:margaret-g-mcglynn-novavax-inc","object_label":"Margaret G. McGlynn","object_source_name_forms":[],"value":"Margaret G. McGlynn: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:margaret-g-mcglynn-novavax-inc","name":"Margaret G. McGlynn"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001628280-26-027328","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-12T16:15:04.417067+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:15","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:maryland-life-sciences-advisory-nvax","object_label":"Maryland Life Sciences Advisory","object_source_name_forms":[],"value":"Maryland Life Sciences Advisory: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:maryland-life-sciences-advisory-nvax","name":"Maryland Life Sciences Advisory"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:175d30715a6589cc3390c7c5ef5468d1daa3d6d31474b1cf67fdbf78252d35bf","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A nvax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T01:29:30.958071+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:16","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:opus-genetics-nvax","object_label":"Opus Genetics","object_source_name_forms":[],"value":"Opus Genetics: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:opus-genetics-nvax","name":"Opus Genetics"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2010-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2010-01-01","valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:175d30715a6589cc3390c7c5ef5468d1daa3d6d31474b1cf67fdbf78252d35bf","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A nvax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T01:29:30.958071+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2010-01-01","effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:17","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:rachel-k-king","object_label":"Rachel K. King","object_source_name_forms":[],"value":"Rachel K. King: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:rachel-k-king","name":"Rachel K. King"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001628280-26-027328","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-12T16:15:04.417067+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:18","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:richard-h-douglas","object_label":"Richard H. Douglas","object_source_name_forms":[],"value":"Richard H. Douglas: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:richard-h-douglas","name":"Richard H. Douglas"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001628280-26-027328","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-12T16:15:04.417067+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:19","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:richard-j-rodgers","object_label":"Richard J. Rodgers","object_source_name_forms":[],"value":"Richard J. Rodgers: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:richard-j-rodgers","name":"Richard J. Rodgers"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001628280-26-027328","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-12T16:15:04.417067+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:20","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:elaine-o-hara","object_label":"Elaine O'Hara","object_source_name_forms":[],"value":"Elaine O'Hara: Executive Vice President, Chief Strategy Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:elaine-o-hara","name":"Elaine O'Hara"},"title":"Executive Vice President, Chief Strategy Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001628280-26-027328","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-12T16:15:04.417067+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:21","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:james-p-kelly","object_label":"James P. Kelly","object_source_name_forms":[],"value":"James P. Kelly: Executive Vice President, Chief Financial Officer and Treasurer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:james-p-kelly","name":"James P. Kelly"},"title":"Executive Vice President, Chief Financial Officer and Treasurer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001628280-26-027328","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-12T16:15:04.417067+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:22","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jeffrey-d-kelly","object_label":"Jeffrey D. Kelly","object_source_name_forms":[],"value":"Jeffrey D. Kelly: Named Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jeffrey-d-kelly","name":"Jeffrey D. Kelly"},"title":"Named Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:f037cb8859aa9e25095f29e05764b56b10350ab06f66b8c57eadc9c4f7908255","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NVAX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-05T00:04:25.73024+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:23","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:john-c-jacobs","object_label":"John C. Jacobs","object_source_name_forms":[],"value":"John C. Jacobs: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:john-c-jacobs","name":"John C. Jacobs"},"title":"President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001628280-26-027328","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-12T16:15:04.417067+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:24","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:john-trizzino","object_label":"John Trizzino","object_source_name_forms":[],"value":"John Trizzino: Named Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:john-trizzino","name":"John Trizzino"},"title":"Named Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:a36ac2691aed7a3541ac0f69a3e80a59a885ba87b4e8c70f9ebaf3fae39fdcff","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NVAX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-05T00:04:27.352145+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:25","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:mark-j-casey","object_label":"Mark J. Casey","object_source_name_forms":[],"value":"Mark J. Casey: Executive Vice President, Chief Legal Officer and Corporate Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:mark-j-casey","name":"Mark J. Casey"},"title":"Executive Vice President, Chief Legal Officer and Corporate Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001628280-26-027328","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-12T16:15:04.417067+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:26","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:michael-casey","object_label":"Michael Casey","object_source_name_forms":[],"value":"Michael Casey: Executive Vice President, Chief Legal Officer and Corporate Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:michael-casey","name":"Michael Casey"},"title":"Executive Vice President, Chief Legal Officer and Corporate Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:61de0a12d94edbeccc0e88cc44025f89f3babb4f66743bdee16ded6b590ccf32","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NVAX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-05T00:04:26.78667+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:leadership_role:27","subject_id":"alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:ruxandra-draghia-akli","object_label":"Ruxandra Draghia-Akli","object_source_name_forms":[],"value":"Ruxandra Draghia-Akli: Named Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:ruxandra-draghia-akli","name":"Ruxandra Draghia-Akli"},"title":"Named Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-18T07:11:51.27144+00:00","sources":[{"id":"alpha:projection-evidence:document:c77f87bd20375542c8cddf23567e8e094e3888e4abe3c6f916a0fe7a84b07fb6","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NVAX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-05T00:04:27.940796+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:ff32d70e8a9b64b3c7d1001af6936750d20ffffcdbdcf3ff3fe14e3618bc587e","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001628280-26-027328","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-12T16:15:04.417067+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:175d30715a6589cc3390c7c5ef5468d1daa3d6d31474b1cf67fdbf78252d35bf","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A nvax-20260427.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-09-02T01:29:30.958071+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:f037cb8859aa9e25095f29e05764b56b10350ab06f66b8c57eadc9c4f7908255","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NVAX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-05T00:04:25.73024+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:a36ac2691aed7a3541ac0f69a3e80a59a885ba87b4e8c70f9ebaf3fae39fdcff","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NVAX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-05T00:04:27.352145+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:61de0a12d94edbeccc0e88cc44025f89f3babb4f66743bdee16ded6b590ccf32","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NVAX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-05T00:04:26.78667+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:c77f87bd20375542c8cddf23567e8e094e3888e4abe3c6f916a0fe7a84b07fb6","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NVAX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-05T00:04:27.940796+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.834,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.904,"cross_source_agreement":0.75,"temporal_completeness":0.478},"diagnostics":{"published_claims":27,"factual_claims":27,"claims_with_linked_evidence":27,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":23,"temporal_claims_with_valid_from":11,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","committee","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-18T07:11:51.27144+00:00","observed_at":"2026-10-18T07:11:51.27144+00:00","reviewed_at":"2026-10-18T07:11:51.27144+00:00","verified_at":"2026-10-18T07:11:51.27144+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":27,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/novavax-inc/relationships","section":"relationships","href":"https://registry.alpha.ac/api/public/companies/novavax-inc?format=record&section=relationships","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}